与死亡相关的蛋白质激酶1:健康和疾病的双刃剑
Xiuli Zhang1, Yehuda G Assaraf2, Yao Lin1
1The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, College of Integrative Medicine, Fujian-Macao Science and Technology Cooperation Base of Traditional Chinese Medicine-Oriented Chronic Disease Prevention and Treatment, Fujian-Hong Kong-Macau-Taiwan Collaborative Laboratory for the Inheritance and Innovation of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
与死亡相关的蛋白激酶1 (DAPK1) 调节细胞的重要功能,如细胞亡和自. 需要进行研究来开发更多用于DAPK1的小分子调节器,以帮助治疗疾病.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 与死亡相关的蛋白激酶1 (DAPK1) 是一个关键的Ca2+/calmodulin调节的激酶.
- 它控制关键的细胞过程,包括亡和自.
- DAPK1的失调与癌症和神经退行等各种疾病有关.
研究的目的:
- 审查DAPK1.1的结构,生物功能和疾病相关性.
- 要突出目前DAPK1.1的小分子调制器的现状.
- 确定DAPK1调制的研究缺口和未来方向.
主要方法:
- 文献综述和对DAPK现有研究的分析1.
- 检查DAPK1在细胞机制和疾病发病过程中的作用.
- 关于已知的DAPK1.1小分子抑制剂和激活剂的信息汇编.
主要成果:
- 详细介绍了DAPK1的复杂调节和广泛的生物影响.
- 它在包括癌症,中风和心血管疾病在内的各种病理方面的参与已经得到证实.
- 证实了DAPK1的小分子调节器的有限可用性.
结论:
- DAPK1是一个重要的治疗点,在健康和疾病中起着关键作用.
- 进一步的研究对于发现新的DAPK1激活剂和抑制剂至关重要.
- 开发新的DAPK1调节器将促进机理学理解和治疗策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...


